- Home
- MHUA vs POAI Comparison
MHUA vs POAI Comparison
Compare MHUA & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- POAI
- Stock Information
- Founded
- MHUA 1990
- POAI 2002
- Country
- MHUA China
- POAI United States
- Employees
- MHUA 619
- POAI N/A
- Industry
- MHUA Medical Specialities
- POAI Industrial Specialties
- Sector
- MHUA Health Care
- POAI Health Care
- Exchange
- MHUA Nasdaq
- POAI Nasdaq
- Market Cap
- MHUA 13.1M
- POAI 8.9M
- IPO Year
- MHUA 2022
- POAI N/A
- Fundamental
- Price
- MHUA $0.53
- POAI $0.93
- Analyst Decision
- MHUA
- POAI Hold
- Analyst Count
- MHUA 0
- POAI 1
- Target Price
- MHUA N/A
- POAI N/A
- AVG Volume (30 Days)
- MHUA 304.3K
- POAI 230.8K
- Earning Date
- MHUA 04-25-2025
- POAI 05-15-2025
- Dividend Yield
- MHUA N/A
- POAI N/A
- EPS Growth
- MHUA N/A
- POAI N/A
- EPS
- MHUA 0.40
- POAI N/A
- Revenue
- MHUA $96,909,642.00
- POAI $1,729,269.00
- Revenue This Year
- MHUA N/A
- POAI $486.27
- Revenue Next Year
- MHUA N/A
- POAI $65.50
- P/E Ratio
- MHUA $1.15
- POAI N/A
- Revenue Growth
- MHUA N/A
- POAI 24.17
- 52 Week Low
- MHUA $0.25
- POAI $0.55
- 52 Week High
- MHUA $1.47
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- MHUA 69.19
- POAI 38.83
- Support Level
- MHUA $0.38
- POAI $0.87
- Resistance Level
- MHUA $0.50
- POAI $0.97
- Average True Range (ATR)
- MHUA 0.05
- POAI 0.07
- MACD
- MHUA 0.01
- POAI -0.02
- Stochastic Oscillator
- MHUA 84.66
- POAI 12.30
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.